Table 5.
Distribution of Parvovirus B19 Virological Markers Among Studied Subjects
| Patients with acute myeloid leukemia | Patients under chemotherapy for acute myeloid leukemia | Control group | ||
|---|---|---|---|---|
| (n=32) | (n=16) | (n=60) | p value | |
| IgM | 12 (37.5%) | 8 (50%) | 2 (3.3%) | 0.0001 |
| PCR | 16 (50%) | 8 (50%) | 0 (0%) | 0.0001 |
| IgG | 11 (34.4%) | 8 (50%) | 7 (11.7%) | 0.0001 |